NCR3 and invasive breast carcinoma: Likewise, intra-tumoral NK cells from invasive breast cancer expressed less NKp30, NKG2D, DNAM-1, CD16, CD25, CD57, perforin, granzyme, and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), as well as higher NKG2A and NKp44 compared to both normal breast tissue and carcinoma in situ (20).